AbbVie
ABBV
#29
Rank
โ‚น35.433 T
Marketcap
โ‚น20,033
Share price
-1.15%
Change (1 day)
15.43%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

Revenue for AbbVie (ABBV)

Revenue in 2025 (TTM): โ‚น5.355 Trillion

According to AbbVie's latest financial reports the company's current revenue (TTM ) is โ‚น5.699 Trillion. an increase over the revenue in the year 2024 that were of โ‚น4.832 Trillion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for AbbVie from 2011 to 2025

Annual revenue

Year Revenue Change
2025 โ‚น5.490 T13.61%
2024 โ‚น4.832 T6.87%
2023 โ‚น4.521 T-5.87%
2022 โ‚น4.803 T14.85%
2021 โ‚น4.182 T24.87%
2020 โ‚น3.349 T41.21%
2019 โ‚น2.372 T3.58%
2018 โ‚น2.290 T27.12%
2017 โ‚น1.801 T3.41%
2016 โ‚น1.742 T14.69%
2015 โ‚น1.519 T20.08%
2014 โ‚น1.265 T8.97%
2013 โ‚น1.160 T15.35%
2012 โ‚น1.006 T9.06%
2011 โ‚น922.78 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Pfizer
PFE
โ‚น5.831 T 2.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚น6.073 T 6.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚น3.424 T-39.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
โ‚น921.66 B-83.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
โ‚น2.743 T-51.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น4.491 T-21.20%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
โ‚น5.473 T-3.96%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
โ‚น4.079 T-28.43%๐Ÿ‡ฌ๐Ÿ‡ง UK
Neurocrine Biosciences
NBIX
โ‚น266.55 B-95.32%๐Ÿ‡บ๐Ÿ‡ธ USA